IPO hopefuls swing for $126.5M and hope biotech’s window stays open

Damian Garde After two consecutive quarters of mostly bullish biotech debuts, two drugmakers are lining up IPOs in hopes the market stays drug-friendly, seeking a combined $ 126.5 ...

GlaxoSmithKline’s darapladib team finds hope in a PhIII bomb

John Carroll No matter how badly a drug fails in Phase III, investigators and the companies that employ them often bend over backward to highlight any positive sign of efficacy, no ...

LUNGevity Foundation’s Celebration of Hope Gala a Huge Success

mia.burns Over $ 800,000 Raised for Lung Cancer Research Oct. 4, 2013–LUNGevity Foundation brought together over 350 philanthropists, business community leaders, and ...

Ray of hope in Merck cost-cutting gloom: New cancer-immunotherapy data

Tracy Staton While headlines focused on Merck's 8,500-job, $ 2.5 billion restructuring yesterday, the pharma giant quietly posted promising early-stage data on what has become ...

ArQule rises on renewed hope for twice-damned tivantinib

Damian Garde ArQule watched its shares scrape the bottom last fall when it pulled the plug on a late-stage lung cancer drug, but rumors that the Woburn, MA, company is primed to release ...

Biotech Ruthigen seeks IPO boost for preclinical hope

Ryan McBride With the IPO market increasingly appetizing to all manner of biotech companies, the little-known outfit Ruthigen has filed paperwork to raise up to $ 26.7 million in a ...

Pharma professionals feeling angst, but see a few rays of hope

Eric Palmer With the patent cliff continuing to fell blockbusters, with earnings suffering as a result and layoffs and retrenchments often the response, it is no surprise that a little ...

Pfizer’s vaccine hope Prevenar 13 wins new EU nod in adults

Tracy Staton One reason Pfizer snapped up Wyeth in 2009: Its Prevnar/Prevenar vaccine franchise. Now, the latest version of the pneumococcal shot is Pfizer's fourth-biggest seller, ...

Hope to see you in Chicago for #BIO2013

Jennifer Levin We’ll be in Chicago next week for BIO’s International Convention. Here are a few things on our agenda–hope to see you there! Only a handful of seats ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS